Literature DB >> 24510758

Volumetric and positional changes of planning target volumes and organs at risk using computed tomography imaging during intensity-modulated radiation therapy for head-neck cancer: an "old" adaptive radiation therapy approach.

Alessia Reali1, Silvia Maria Anglesio, Gianluca Mortellaro, Simona Allis, Sara Bartoncini, Maria Grazia Ruo Redda, Francesca Arcadipane.   

Abstract

PURPOSE: This study aimed to assess, in a department of radiation oncology not equipped with in-room imaging systems, volumetric and positional changes of planning target volumes (PTVs) and organs at risk in head and neck (H&N) cancer patients treated with intensity-modulated radiation therapy (IMRT), using consecutive off-board computed tomography (CT) imaging. Dosimetric aspects were not investigated.
MATERIALS AND METHODS: Ten patients with H&N cancer underwent CT re-scanning at 3, 5, and 7 weeks. Positional changes of the PTVs and parotid glands as distances relative to the virtual isocentre were determined. The parotids glands (PGs) were re-delineated on each CT set and volume differences were computed. Anterior-posterior (AP) and latero-lateral (LL) displacements for the spinal cord at C1 and C6 level were calculated. Changes in patient body contours were evaluated by comparing the volumes within the external skin outline.
RESULTS: Apart from two patients requiring re-planning due to substantial weight loss, our results evidenced no significant shifts of PTVs and PGs. PG volume decreased with a trend in volume reduction for the ipsilateral parotid. No significant shift of spinal cord at C1 and C6 level was detected, in either the AP or LL direction. The collected data demonstrated a trend in external skin contour volume loss.
CONCLUSIONS: Our preliminary results reflect the literature data and indicate that an off-line adaptive RT approach is appropriate in clinical practice.

Entities:  

Mesh:

Year:  2014        PMID: 24510758     DOI: 10.1007/s11547-014-0386-z

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  18 in total

1.  Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the TomoTherapy HiArt™ system.

Authors:  H Loo; J Fairfoul; A Chakrabarti; J C Dean; R J Benson; S J Jefferies; N G Burnet
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-10-06       Impact factor: 4.126

2.  The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  Liang Zhao; Qiuyan Wan; Yongqiang Zhou; Xia Deng; Congyin Xie; Shixiu Wu
Journal:  Radiother Oncol       Date:  2010-10-30       Impact factor: 6.280

3.  Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study.

Authors:  Shreerang A Bhide; Mark Davies; Kevin Burke; Helen A McNair; Vibeke Hansen; Y Barbachano; I A El-Hariry; Kate Newbold; Kevin J Harrington; Christopher M Nutting
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04       Impact factor: 7.038

Review 4.  Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

Authors:  Avraham Eisbruch; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

5.  Multimodality image fusion and planning and dose delivery for radiation therapy.

Authors:  Cheng B Saw; Hungcheng Chen; Ron E Beatty; Henry Wagner
Journal:  Med Dosim       Date:  2008-04-01       Impact factor: 1.482

6.  Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation.

Authors:  Pierre Castadot; Xavier Geets; John Aldo Lee; Nicolas Christian; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2010-04-10       Impact factor: 6.280

Review 7.  Adaptive radiotherapy of head and neck cancer.

Authors:  Pierre Castadot; John A Lee; Xavier Geets; Vincent Grégoire
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

8.  Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.

Authors:  David L Schwartz; Adam S Garden; Jimmy Thomas; Yipei Chen; Yongbin Zhang; Jan Lewin; Mark S Chambers; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-02       Impact factor: 7.038

9.  Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?

Authors:  Jennifer C O'Daniel; Adam S Garden; David L Schwartz; He Wang; Kian K Ang; Anesa Ahamad; David I Rosenthal; William H Morrison; Joshua A Asper; Lifei Zhang; Shih-Ming Tung; Radhe Mohan; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-15       Impact factor: 7.038

Review 10.  Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets.

Authors:  Avraham Eisbruch; Robert L Foote; Brian O'Sullivan; Jonathan J Beitler; Bhadrasain Vikram
Journal:  Semin Radiat Oncol       Date:  2002-07       Impact factor: 5.934

View more
  7 in total

1.  Are intraoral customized stents still necessary in the era of Highly Conformal Radiotherapy for Head & Neck cancer? Case series and literature review.

Authors:  P Appendino; F Della Ferrera; D Nassisi; G Blandino; E Gino; S D Solla; M G Ruo Redda
Journal:  Rep Pract Oncol Radiother       Date:  2019-08-20

2.  Longitudinal fan-beam computed tomography dataset for head-and-neck squamous cell carcinoma patients.

Authors:  Tatiana Bejarano; Mariluz De Ornelas-Couto; Ivaylo B Mihaylov
Journal:  Med Phys       Date:  2019-03-12       Impact factor: 4.071

3.  Letter to the Editor concerning Bhandari et al. "Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers".

Authors:  Maria Grazia Ruo Redda; Alessia Reali; Simona Allis; Silvia Maria Anglesio; Roberta Verna; Lavinia Bianco
Journal:  J Med Phys       Date:  2014-10

4.  Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.

Authors:  Jingjiao Lou; Pu Huang; Changsheng Ma; Yue Zheng; Jinhu Chen; Yueqiang Liang; Hongsheng Li; Yong Yin; Danhua Liu; Gang Yu; Dengwang Li
Journal:  J Appl Clin Med Phys       Date:  2018-04-17       Impact factor: 2.102

5.  Delta-radiomics features during radiotherapy improve the prediction of late xerostomia.

Authors:  Lisanne V van Dijk; Johannes A Langendijk; Tian-Tian Zhai; Thea A Vedelaar; Walter Noordzij; Roel J H M Steenbakkers; Nanna M Sijtsema
Journal:  Sci Rep       Date:  2019-08-28       Impact factor: 4.379

6.  Impact of adaptive intensity-modulated radiotherapy on the neutrophil-to-lymphocyte ratio in patients with nasopharyngeal carcinoma.

Authors:  Ning Han; Xintong Lyu; Guang Li; Qiao Qiao
Journal:  Radiat Oncol       Date:  2019-08-22       Impact factor: 3.481

7.  Radiotherapy for Head and Neck Cancer: Evaluation of Triggered Adaptive Replanning in Routine Practice.

Authors:  Metin Figen; Didem Çolpan Öksüz; Evrim Duman; Robin Prestwich; Karen Dyker; Kate Cardale; Satiavani Ramasamy; Patrick Murray; Mehmet Şen
Journal:  Front Oncol       Date:  2020-11-12       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.